Zymeworks Q1 2024 GAAP EPS $(0.42) Misses $(0.29) Estimate, Sales $10.030M Miss $17.431M Estimate
Zymeworks Q1 2024 GAAP EPS $(0.42) Misses $(0.29) Estimate, Sales $10.030M Miss $17.431M Estimate
Zymeworks 2024 年第一季度公认会计准则每股收益 (0.42) 未达到预期 (0.29) 美元，销售额为 100.3 亿美元，低于预期 174.31 亿美元
Zymeworks (NYSE:ZYME) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.29) by 44.83 percent. This is a 13.51 percent decrease over losses of $(0.37) per share from the same period last year. The company reported quarterly sales of $10.030 million which missed the analyst consensus estimate of $17.431 million by 42.46 percent. This is a 71.81 percent decrease over sales of $35.578 million the same period last year.
Zymeworks（纽约证券交易所代码：ZYME）公布的季度亏损为每股0.42美元，比分析师普遍预期的0.29美元（0.29美元）低44.83％。这比去年同期每股亏损0.37美元（0.37）下降了13.51％。该公司公布的季度销售额为100.3亿美元，比分析师普遍预期的1743.1万美元低42.46％。这比去年同期的355.78万美元的销售额下降了71.81％。